About: Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on May 1998

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 1998 (ast) наукова стаття, опублікована в травні 1998 (uk) مقالة علمية نشرت في مايو 1998 (ar) scientific article published on May 1998 (en)
publication date	wds:Q37381313-6987D3C5-B164-49A6-890B-F35E47852863
publication date	1998-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37381313-0EA3A2FD-C68A-4A9E-968B-9EC2006A4601
language of work or name	English
cites work	wds:Q37381313-0F8FE43E-5265-4C49-9B2E-805CF046B8C3 wds:Q37381313-0FF2A82E-5A31-42AB-992B-E3D91F907C4E wds:Q37381313-10989586-AD61-486B-B0C6-98D148C31D5F wds:Q37381313-15859C22-D9CE-4371-9C17-EA1079666A5B wds:Q37381313-1F3A69EF-C6DE-4483-8A75-EF4752C8CA61 wds:Q37381313-2B91EBB9-A823-4EDA-B5DD-5D224CABC509 wds:Q37381313-317ACBCE-E739-4D8B-8E92-5B2A69A41650 wds:Q37381313-432D057F-3E4C-410A-B00E-A770EB3E6D19 wds:Q37381313-58387B76-C350-4424-BA15-1DFFF2E45790 wds:Q37381313-5C5E9F9F-6E8C-4002-9772-A220F2978B4E wds:Q37381313-618508B7-6F6A-4C93-B670-D1F7210C7AEC wds:Q37381313-630B9227-3A8F-4C83-869F-CFCBD013B46B wds:Q37381313-632451EB-7813-46EB-B310-B199A7CC807A wds:Q37381313-69071A28-F93D-48A9-A233-B1961A0C2746 wds:Q37381313-7CC6144F-6D38-4416-917D-8495C4C1A490 wds:Q37381313-8363C967-FB2E-4288-A8A8-A20C0DD79A1E wds:Q37381313-88EF4478-FF59-4C2D-BD5B-C222B8861A4F wds:Q37381313-9B6329C9-4FEA-4443-BF2A-31916279F1BF wds:Q37381313-AB58272D-99DE-4DAD-B63C-F3DFF3286C9D wds:Q37381313-BA4902BC-ECD1-4B29-A075-03E7DEBE7F1D wds:Q37381313-CB9B0AED-E674-46C4-899C-689E643DB407 wds:Q37381313-D2F28767-A7AC-4264-823B-80A00BA5A1DB wds:Q37381313-E51E2A0E-650A-43B8-A002-A4F60FF036BB wds:Q37381313-FE6C90F9-D1DD-42E7-B188-26537F34E7BD
cites work	Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice Biology of natural killer cells Donor-type activated natural killer cells promote marrow engraftment and B cell development during allogeneic bone marrow transplantation Prevention of murine graft-versus-host disease by inducing and eliminating ASGM1+ cells of donor origin Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. T-cell depletion of HLA-identical transplants in leukemia. Graft-versus-host disease Bone marrow transplantation Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey Interleukin-12 inhibits murine graft-versus-host disease Transforming growth factor-beta and the immune system Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes Systemic interleukin-2 therapy in children with progressive neuroblastoma after high dose chemotherapy and bone marrow transplantation Bone marrow transplantation Natural killer cells and bone marrow transplantation IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells
author name string	wds:Q37381313-47A14724-03F4-42E1-BCA4-3EB83C82076C wds:Q37381313-64B0C9EF-F3E2-458E-823B-CD61DAE233D0 wds:Q37381313-78AE8CF4-2DF2-4512-B32F-8208AA64E1CE wds:Q37381313-EC9383F6-F268-4083-BE5C-A5B310BC4058
author name string	Tian ZG Asai O Taub DD Hornung RL
rdfs:label	Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (en) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (nl) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (ast)
skos:prefLabel	Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (en) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (nl) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (ast)
name	Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (en) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (nl) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (ast)
author	wds:Q37381313-318974F8-6C93-4141-BB37-B5B69807C7C2 wds:Q37381313-39a5c87f-4b5e-e93c-8fd7-3739d132106f wds:Q37381313-E3CFD654-BC8A-4C69-9311-0DBE0007FF21
author	Dan Longo William J. Murphy Francis W. Ruscetti
title	wds:Q37381313-F4B5D9AC-0524-44BC-BECB-C2FFF3EFF922
title	Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation (en)
page(s)	wds:Q37381313-E726E202-6669-42FF-B180-63B412D33F4D
page(s)	1835-1842
instance of	wds:Q37381313-92E0125C-5615-4A08-8666-F010DF843AC4
instance of	scholarly article
main subject	wds:Q37381313-5732CD1D-27CC-4D99-94A3-F30D0AE19769
main subject	bone marrow

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software